SCHEMBL8708152

SCHEMBL8708152

Nc1nc(-c2cccc(C(F)(F)F)c2)c(Br)s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORB Q92753 8/20 0.60
ADORA1 P30542 3/20 0.51
ADORA2A P29274 2/20 0.51
EPHX2 P34913 1/20 0.44
SCN4A P35499 1/20 0.44
XDH P47989 1/20 0.44
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MPL P40238 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
MYC P01106 1/20 0.42
WDR5 P61964 1/20 0.42
RORC P51449 1/20 0.42
IKBKB O14920 1/20 0.42
BRD4 O60885 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8707497 0.82 ADORA1 (0.48) RORBADORA1ADORA2AMEN1ALOX15
SCHEMBL28647149 0.80 MAPT (0.51) RORBADORA1ADORA2AMEN1MAPT
SCHEMBL1853775 0.79 RORB (0.52) RORBADORA1ADORA2AEPHX2SCN4A
SCHEMBL6258242 0.78 RORB (0.69) RORBADORA1ADORA2AMEN1KMT2A
SCHEMBL2492021 0.78 RORB (0.69) RORBADORA1ADORA2ARORC
SCHEMBL6233722 0.78 RORB (0.47) RORBADORA1ADORA2AEPHX2SCN4A
SCHEMBL12495322 0.77 RORB (0.53) RORBADORA1ADORA2AMEN1MAPT
SCHEMBL18042050 0.77 ALDH1A1 (0.51) RORBADORA1XDHMEN1MAPT
SCHEMBL1256622 0.76 MAPT (0.63) MEN1MAPTALOX15ALOX12KMT2A
SCHEMBL12495307 0.73 ADORA2A (0.52) ADORA1ADORA2AXDHMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109415371-B 2-amido thiazole derivative and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-07-09 CN disclosed
US-20190315771-A1 NOVEL 2-ACYLAMINOTHIAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2019-10-17 US disclosed
EP-3511332-A1 NOVEL 2-ACYLAMINOTHIAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2019-07-17 EP disclosed
EP-3511332-A1 NOVEL 2-ACYLAMINOTHIAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2019-07-17 EP disclosed
WO-2012100734-A1 COMPOUNDS USEFUL AS RETINOID-RELATED ORPHAN RECEPTOR GAMMA MODULATORS GLAXO GROUP LIMITED (GB) 2012-08-02 WO disclosed
WO-1998023155-A1 ARTHROPODICIDAL AND FUNGICIDAL CYCLIC AMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-06-04 WO disclosed
WO-1997000612-A1 ARTHROPODICIDAL AND FUNGICIDAL CYCLIC AMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190315771-A1 NOVEL 2-ACYLAMINOTHIAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF TEK, MPL, THPO RORB 1678/4885ADORA1 504/4885ADORA2A 1106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.